5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity

BACKGROUND: Magnetic resonance imaging (MRI) scans are increasingly first-line investigations for suspected prostate cancer, and essential in the decision for biopsy. 5-alpha reductase inhibitor (5-ARI) use has been shown to reduce prostate size and prostate cancer risk. However, insufficient data e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziting, Wang, Kaiying, Ong, Han Yang, Tsang, Woon Chau, Wu, Qing Hui, Chiong, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105450/
https://www.ncbi.nlm.nih.gov/pubmed/37061671
http://dx.doi.org/10.1186/s12894-023-01235-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105450/
https://www.ncbi.nlm.nih.gov/pubmed/37061671
http://dx.doi.org/10.1186/s12894-023-01235-4

Ejemplares similares